However, TACE may increase tumor hypoxia, leading to the upregulation of vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF), promotion of tumor angiogenesis (4), and tumor recurrence or metastasis. This evidence concerns the gene VEGFA and neoplasm.